IMWG Consensus Statement Regarding the Current Status of Allogeneic Stem Cell Transplantation for Multiple Myeloma
International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Cavo - How I treat a patient eligible for high dose therapy and auto-transplant?
STEM CELL TRANSPLANT: The Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma
Long-Term Follow-Up of Autotransplantation Trials for Multiple Myeloma: Update of Protocols Conducted by the Intergroupe Francophone du Myelome, Southwest Oncology Group, and University of Arkansas for Medical Sciences
STEM CELL TRANSPLANT: The current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
STEM CELL TRANSPLANT: Mobilization in myeloma revisited: Perspectives on stem cell collection following initial therapy with thalidomide, lenalidomide or bortezomib-containing regimens